CSIMarket Company Name, Ticker, Suppliers, else..


Baudax Bio Inc   (NASDAQ: BXRX)
Other Ticker:  
 

Baudax Bio Inc

BXRX's Fundamental analysis



Baudax Bio Inc 's sales fell in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 2141

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.76 %

Baudax Bio Inc net loss decreased from $-29 millions, to $-2 millions in III. Quarter 2023,

• More on BXRX's Growth


Baudax Bio Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Baudax Bio Inc PEG ratio is at -0 Baudax Bio Inc realized cash reduction of $ -0.56 per share in trailing twelve-month period.
Company
0.01
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.53.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.


• More on BXRX's Valuation
 
 Total Debt (Millions $) 4
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) -2.87

Baudax Bio Inc
current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.

Baudax Bio Inc PEG ratio is at -0 Baudax Bio Inc realized cash outflow of $ -0.56per share in trailing twelve-month period.
Company
0.01
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.53.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.22.


• More on BXRX's Valuation

•  Market Capitalization (Millions $) 0
•  Shares Outstanding (Millions) 8
•  Employees 16
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -7
•  Cash Flow (TTM) (Millions $) -4
•  Capital Exp. (TTM) (Millions $) 0
•  Total Debt (Millions $) 4
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) -2.87

•  Market Capitalization (Millions $) 0
•  Shares Outstanding (Millions) 8
•  Employees 16
•  Revenues (TTM) (Millions $) -
•  Net Income (TTM) (Millions $) -7
•  Cash Flow (TTM) (Millions $) -4
•  Capital Exp. (TTM) (Millions $) 0





  Ratio
•   Capital Ratio (MRQ) 0.07
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) -
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com